Innovent Unveils IAR177: A New Era In Rheumatology
Setting the Stage for Rheumatic Disease Breakthroughs Innovent Biologics is coming out of the gates hot with its recent presentation at the ACR Convergence 2026, delivering some jaw-dropping preclinical data on its fledgling bispecific antibody, IAR177. Situated in Orlando, this showcase sounds like a real advancement in tackling the uphill battle of rheumatic diseases....
Continue Reading